Key result
Cardiac allograft vasculopathy is linked to ~16% higher fibroatheroma odds per year despite LDL control.
Cohort (n=10)
No
Answers are grounded in this paper and cite their sources.
Retrospective study reveals persistent inflammatory plaque progression via optical coherence tomography in heart transplant recipients, highlighting early risk stratification.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Arai et al. (2026) conducted a cohort in Cardiac allograft vasculopathy in heart transplantation recipients (n=10). Cardiac allograft vasculopathy (ISHLT grades 1-3 at 1 year) vs. No cardiac allograft vasculopathy (ISHLT grade 0 at 1 year) was evaluated on Annual progression of fibroatheroma prevalence on optical coherence tomography over 5 years in the CAV group (OR 1.16 per year, 95% CI 1.06-1.28, p=0.002). Cardiac allograft vasculopathy was associated with progressive increases in fibroatheroma over 5 years on serial OCT despite LDL control.
Synapse has enriched 10 related papers. Consider them for comparative context: